Krystal Biotech Inc (KRYS)

159.76 +3.95 (+2.54%) USD  |  NASDAQ  |  Jan 07, 16:00
159.76 0.00 (0.00%) After-Hours: 16:27
More

Krystal Biotech Research and Development Expense (Annual): 46.43M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Alnylam Pharmaceuticals Inc 1.004B
Amicus Therapeutics Inc 152.38M
Insmed Inc 571.01M
Rhythm Pharmaceuticals Inc 134.95M
Apellis Pharmaceuticals Inc 354.39M